{
    "organizations": [],
    "uuid": "d22b14a706bc8f5d292ebcde4f977c70a5a95f75",
    "author": "Charley Grant",
    "url": "https://www.wsj.com/articles/shire-investors-can-profit-from-takeda-skepticism-1525795630",
    "ord_in_thread": 0,
    "title": "Shire Investors Can Profit From Takeda Skepticism",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Making a $62 billion acquisition work for your investors isnâ€™t easy, but the odds of success for Takeda Pharmaceuticals with Shire are higher than the market currently thinks.\nThe cash and stock deal will solve a major strategic problem for Takeda since drug sales in Japan are falling due to an aging population and fairly strict government regulations on drug prices. Shire books a majority of its sales in the U.S., where the long term industry outlook is brighter and pricing is more permissive.\n... ",
    "published": "2018-05-08T20:07:00.000+03:00",
    "crawled": "2018-05-08T23:52:09.042+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "making",
        "billion",
        "acquisition",
        "work",
        "investor",
        "easy",
        "odds",
        "success",
        "takeda",
        "pharmaceutical",
        "shire",
        "higher",
        "market",
        "currently",
        "think",
        "cash",
        "stock",
        "deal",
        "solve",
        "major",
        "strategic",
        "problem",
        "takeda",
        "since",
        "drug",
        "sale",
        "japan",
        "falling",
        "due",
        "aging",
        "population",
        "fairly",
        "strict",
        "government",
        "regulation",
        "drug",
        "price",
        "shire",
        "book",
        "majority",
        "sale",
        "long",
        "term",
        "industry",
        "outlook",
        "brighter",
        "pricing",
        "permissive"
    ]
}